Investors

Oncorus closed a successful $61M Series A in July 2016 led by MPM Capital.   Also joining the round were Deerfield Management, Arkin Bio Ventures, Celgene, Inc, Astellas, Excelyrate Capital, Long March Investment Fund and MPM SunStates Fund.

 

Platform Partners

At Oncorus, we are committed to bringing innovative therapies to patients in need.  

If you have an interest in our platform and believe we can work together to achieve this vision, please reach out at partnering@oncorus.com.